Table 1 Cell lines used in this study
Cell line | Age (years) | Source | ER | PR | HER2 | Number of passages after obtention from ATCC |
|---|---|---|---|---|---|---|
MCF-7 | 69 | Pleural Effusion | + | + | − | 7–30 |
T47D | 54 | Pleural Effusion | + | +, Amp | − | 6–8 |
BT20 | 74 | Primary Tumor | − | − | − | 6–11 |
HCC1806 | 60 | Primary Tumor | − | − | − | 20–23 |
